{"abstract":"The Food and Drug Administration (FDA) is contemplating the grant of an Exclusive Patent License to practice the invention embodied in the U.S. Patent listed in the Supplementary Information section of this notice to Advion, Inc. located in Ithaca, New York.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/11/13/2020-25142.html","cfr_references":[],"citation":"85 FR 72672","comment_url":null,"comments_close_on":"2020-11-30","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the Food and Drug Administration's Technology Transfer Program on or before November 30, 2020 will be considered.","disposition_notes":null,"docket_ids":["Docket No. FDA-2020-N-1992"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2020-11-13","updated_at":"2023-02-28T22:38:23.231-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2020-N-1992-0001","allow_late_comments":null,"id":"FDA-2020-N-1992-0001","comment_end_date":"2020-12-01","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2020-N-1992","title":"Prospective Grant of an Exclusive Patent License:  Field-deployable mass spectrometer diagnostic for SARS, SARS-CoV-2 and other viruses, bacteria and bacterial serovar and drug impurities"}],"document_number":"2020-25142","effective_on":null,"end_page":72672,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/11/13/2020-25142.xml","html_url":"https://www.federalregister.gov/documents/2020/11/13/2020-25142/prospective-grant-of-an-exclusive-patent-license-field-deployable-mass-spectrometer-diagnostic-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-25142?publication_date=2020-11-13","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-11-13/2020-25142/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":389,"last_updated":"2026-10-23 20:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-11-13/pdf/2020-25142.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-25142.pdf?1605188742","publication_date":"2020-11-13","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/11/13/2020-25142.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2020-N-1992","supporting_documents_count":0,"docket_id":"FDA-2020-N-1992","document_id":"FDA-2020-N-1992-0001","regulation_id_number":null,"title":"Prospective Grant of an Exclusive Patent License:  Field-deployable mass spectrometer diagnostic for SARS, SARS-CoV-2 and other viruses, bacteria and bacterial serovar and drug impurities","checked_regulationsdotgov_at":"2023-03-01T03:38:22Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":72672,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Field-Deployable Mass Spectrometer Diagnostic for SARS, SARS-CoV-2 and Other Viruses, Bacteria and Bacterial Serovar, and Drug Impurities","toc_doc":"Field-Deployable Mass Spectrometer Diagnostic for SARS, SARSCoV2 and Other Viruses, Bacteria and Bacterial Serovar, and Drug Impurities","toc_subject":"Prospective Grant of an Exclusive Patent License:\n","topics":[],"type":"Notice","volume":85}